{"disease":{"id":"adrenal-hyperplasia-congenital","name":"adrenal hyperplasia congenital"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT03589144","title":"LC-MS / MS Adrenal Steroids Assayed on Dried Blot Spot for the Congenital Adrenal Hyperplasia Neonatal Screening (SPECTROSPOT)","phase":"","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05228652","title":"Questionnaire Study to Assess the Outcomes of the Management of Congenital Adrenal Hyperplasia Individuals","phase":"","overall_status":"UNKNOWN","enrollment_count":61,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT05907291","title":"Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Crinetics Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT03162172","title":"Growth Hormone (GH) in Congenital Adrenal Hyperplasia","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03257462","title":"Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Spruce Biosciences","has_results":true},{"nct_id":"NCT03687242","title":"Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Spruce Biosciences","has_results":true},{"nct_id":"NCT03718234","title":"Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"University of Minnesota","has_results":true}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}